Delivery Order SPE2DB24D1007-SPE2DB24FBYXD
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is for the delivery of 4,560,678,255 units of Rosuvastatin Calcium 10 mg tablets. The $1,305.52 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, under contract number SPE2DX15D1205|SPE2DX23F56W7. The contract has an ultimate completion date of April 24, 2023. Amerisourcebergen holds a significant Indefinite Delivery...
- The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,264.67 Firm Fixed Price contract is for the delivery of 4,563,238,060 units of Rosuvastatin Calcium 5 mg tablets. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,592.52 Firm Fixed Price Delivery Order is for the supply of 4,567,058 units of Rosuvastatin Calcium 5 mg tablets. The award has an ultimate completion date of January 28, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $17,373.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rosuvastatin Calcium 5 mg tablets in quantities of 500 tablets, with a completion date of April 18, 2023. This is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of 4,563,482,111 units of Rosuvastatin Calcium 20 mg tablets in 500-count bottles, with a firm fixed price of $6,400.32 and a completion date of January 31, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,668.55 firm fixed-price delivery order contract covers the supply of 500 count bottles of 5 mg Rosuvastatin Calcium tablets. The contract has an ultimate completion date of July 30, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,509.60 firm fixed-price delivery order is for the supply of 4,563,731,412 units of Rosuvastatin Calcium 20 mg tablets. The contract has a period of performance through February 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,154.47 Firm Fixed Price delivery order is for the supply of Rosuvastatin Calcium 10 mg tablets to DLA facilities. The award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 500 units of Rosuvastatin Calcium 40 mg tablets. The $15,497.62 firm fixed-price delivery order contract has a completion date of May 22, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the provision of Rosuvastatin Calcium 5 mg tablets in 500 count packages. The $6,532.20 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) and has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and has been awarded numerous similar pharmaceutical and medical supply contracts by DLA to...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB24FBYXDDelivery Order
This federal contract award, valued at $162,061.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The award is a firm fixed price delivery order for the supply of 4564016671 - Rosuvastatin Calcium 10 mg tablets in 500-count bottles. The contract has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, valued at up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $162.1k | 3/19/24 |